Examples of using Hypercalcaemia in English and their translations into Romanian
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
-
Programming
Hypo- or hypercalcaemia.
Of thiazide type diuretics may lead to hypercalcaemia in.
Rare: Hypercalcaemia greater than 3.25 mmol/L.
Pre-existing hypercalcaemia.
Hypercalcaemia was reported in clinical trials with Natpar.
Refractory hypokalaemia, hypercalcaemia.
Hypercalcaemia, hypermagnesaemia, hypernatraemia, weight decreased.
Refractory hypokalaemia, hypercalcaemia.
Marked hypercalcaemia may be evidence of hidden hyperparathyroidism.
Patients with CKD may develop hypocalcaemia or hypercalcaemia.
Not known: diabetes mellitus, hypercalcaemia, hyperphosphataemia.
Uncommon: Hypercalcaemia greater than 2.76 mmol/L, hyperuricemia.
Patients with renal insufficiency may develop hypocalcaemia or hypercalcaemia.
Hypercalcaemia of any cause may predispose to digitalis toxicity.
Bondronat was also effective in treating hypercalcaemia caused by tumours.
Marked hypercalcaemia may be evidence of hidden hyperparathyroidism.
Amylase increased, blood bilirubin increased, hypercalcaemia.
Marked hypercalcaemia may be evidence of hidden hyperparathyroidism.
Bisphosphonates are also useful for the treatment of pain and hypercalcaemia.
In patients with hypercalcaemia, Zometa was more effective than pamidronate.
Repeated treatment may be considered in case of recurrent hypercalcaemia or insufficient efficacy.
Marked hypercalcaemia may be evidence of hidden hyperparathyroidism.
Rasitrio should be discontinued if hypercalcaemia develops during treatment.
Reduce hypercalcaemia(high blood calcium levels) in patients with parathyroid carcinoma cancer.
Imprida HCT should be discontinued if hypercalcaemia develops during treatment.
Hyponatraemia, hypercalcaemia, symptomatic hyperuricaemia and refractory hypokalaemia.
Rasilez HCT should be discontinued if hypercalcaemia develops during treatment.
Hypercalcaemia Hydrochlorothiazide stimulates renal calcium reabsorption and may cause hypercalcaemia.
In most patients with severe hypercalcaemia albumin-corrected serum calcium*.
In study CA209017, hypercalcaemia was more frequently reported in the nivolumab group(31/130, 24%) than in the docetaxel group(9/124, 7%).